Evidence map›Paper›PMID 28724561›Full record

ReviewEuropean respiratory review : an official journal of the European Respiratory Society2017

Management of antithrombotic agents in patients undergoing flexible bronchoscopy.

Sami Abuqayyas, Shine Raju, John R Bartholomew, Roulan Abu Hweij, Atul C Mehta

Open access · diamondAbstract readReview
In one paragraph

Review in European respiratory review : an official journal of the European Respiratory Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Pharmacological approach to iatrogenic bleeding during bronchoscopy: what do we know so far and where do we go from here?Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Survey of management of iatrogenic bleeding following bronchoscopic sampling.European respiratory review : an official journal of the European Respiratory Society · 2018
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sami AbuqayyasInternal Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
Shine RajuRespiratory Institute, Cleveland Clinic, Cleveland, OH, USA.
John R BartholomewVascular Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
Roulan Abu HweijInternal Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
Atul C MehtaRespiratory Institute, Cleveland Clinic, Cleveland, OH, USA mehtaa1@ccf.org.
Cleveland Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bleeding is one of the most feared complications of flexible bronchoscopy. Although infrequent, it can be catastrophic and result in fatal outcomes. Compared to other endoscopic procedures, the risk of morbidity and mortality from the bleeding is increased, as even a small amount of blood can fill the tracheobronchial tree and lead to respiratory failure. Patients using antithrombotic agents (ATAs) have higher bleeding risk. A thorough understanding of the different ATAs is critical to manage patients during the peri-procedural period. A decision to stop an ATA before bronchoscopy should take into account a variety of factors, including indication for its use and the type of procedure. This article serves as a detailed review on the different ATAs, their pharmacokinetics and the pre- and post-bronchoscopy management of patients receiving these medications.

Indexed as

AnticoagulantsBronchoscopyClinical Decision-MakingDrug Administration ScheduleFibrinolytic AgentsHemorrhageHumansPlatelet Aggregation InhibitorsRisk AssessmentRisk FactorsAnticoagulantsFibrinolytic AgentsPlatelet Aggregation Inhibitors

Identifiers

PMID28724561
PMCPMC9488780
OpenAlexW2736996880

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.